In this paper, we focus on applications explicitly associated with new developments in the field of NF1, particularly peripheral glial (Schwann cell-derived) and central glial tumors (astrocytomas), which are typically linked to the disease. The gene discussed is NF1; the disease is astrocytoma (excluding glioblastoma).